Short answer
CareDx, Inc. (CDNA) filed an 8-K current report with the SEC on April 16, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1), Item 1.01 (Entry into a Material Definitive Agreement). Item 1.01 references an incorporated exhibit but provides no substantive agreement terms.
CareDx, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Item 1.01 references an incorporated exhibit but provides no substantive agreement terms
- Investors should review the referenced exhibit for counterparties, obligations, duration, and financial impact
Item 2.02 · Results of Operations and Financial Condition
- Exhibit 99.1 contains transaction-related forward-looking statements, not fiscal-year operating results
- Completion depends on closing conditions, regulatory approvals, and third-party consents
- Transaction timing and completion remain uncertain, creating execution risk for investors
- Exhibit 99.1 excluded from Exchange Act Section 18 liability and generally not incorporated by reference
Item 7.01 · Regulation FD Disclosure
- CareDx announced a purchase agreement and related transaction on April 15, 2026
- Investors should review the accompanying press release for transaction terms and strategic implications
Item EX-99.1 · Exhibit EX-99.1
- $170 million cash divestiture of Lab Products to EuroBio Scientific, pending Swedish regulatory review and targeted closing by Q3 2026
- Perpetual exclusive North American distribution rights for post-transplant monitoring IVD tests retained by CareDx
- Preliminary Q1 revenue $118 million, up 39% year over year; Testing Services revenue $91 million, up 48%
- Testing volume 54,900, up 17%; Patient and Digital Solutions revenue $16 million, up 33%
- Cash, equivalents, and marketable securities approximately $198 million as of March 31, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CareDx, Inc. 8-K filings
Get the next CDNA 8-K as it lands
Follow CDNA for push alerts, or ask the research agent what this filing means.